| Model Number |
100035-05 |
| Medical Device Problem Code |
Patient-Device Incompatibility (2682)
|
| Health Effect - Clinical Code |
Erythema (1840)
|
| Date of Event |
09/01/2014
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
Per clinical trial (b)(4): on (b)(6) 2014, patient underwent left breast revision augmentation and scar revision using a short scar incision.1 piece of galaflex was used.No concomitant procedures were done.On (b)(6) 2014, breast erythema/redness was reported.Patient was treated with medication (cipro, doxycycline, bactroban).Ae resolved on (b)(6) 2014 without sequelae.Review by medical affairs identifies as likely related to the device and serious.
|
| |
|
Additional Manufacturer Narrative
|
|
Based on the information provided, no conclusions can be made.As reported, patient experienced post-op complications of erythema.Medical affairs has assessed the patient¿s postoperative course as being serious and likely related to the study device.No lot number has been provided; therefore, a review of the manufacturing records is not possible.This mdr is being submitted to report the ae of erythema; an additional mdr shall be submitted to report the ae of extrusion.Not returned.
|
| |
|
Search Alerts/Recalls
|